Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current status and performance goals for serum thyroglobulin assays

C A Spencer1, M Takeuchi, M Kazarosyan

  • 1Department of Medicine, University of Southern California, Los Angeles 90033, USA. cspencer@hsc.usc.edu

Clinical Chemistry
|January 1, 1996
PubMed
Summary

Evaluating six serum thyroglobulin (Tg) methods for differentiated thyroid carcinoma monitoring revealed significant variability. Standardization and addressing issues like autoantibody interference are crucial for reliable tumor marker use in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Prolapsus Uteri.

Buffalo medical and surgical journal·2023
Same author

Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes.

Prenatal diagnosis·2008
Same author

National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction.

The Journal of clinical endocrinology and metabolism·2007
Same author

Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.

The Journal of clinical endocrinology and metabolism·2005
Same author

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

The Journal of clinical endocrinology and metabolism·2003
Same author

Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease.

Clinical endocrinology·2003

Area of Science:

  • Endocrinology
  • Oncology
  • Clinical Chemistry

Background:

  • Serum thyroglobulin (Tg) is a vital tumor marker for differentiated thyroid carcinoma (DTC) monitoring.
  • Current methods for Tg measurement exhibit variability, impacting clinical utility.
  • Standardization and performance evaluation are essential for reliable patient management.

Purpose of the Study:

  • To evaluate the clinical utility of six different serum Tg measurement methods (RIA and IMA).
  • To assess methodologic standardization, sensitivity, precision, hook effects, and autoantibody interference.
  • To provide recommendations for optimal Tg assay performance in DTC monitoring.

Main Methods:

  • Comparative evaluation of six commercial Tg assays: DYNOtest Tg, OptiQuant Tg, SELco Tg, Thyroglobulin IRMA, Nichols Chemiluminescent ICMA, and a custom RIA.

Related Experiment Videos

  • Assessment focused on standardization, sensitivity, interassay precision, hook effects, and Tg autoantibody interference.
  • Clinical impact of methodologic issues on serial Tg monitoring was reviewed.

    • Main Results:

    • Significant methodologic differences exist among the evaluated Tg assays.
    • Variability in sensitivity, precision, and interference can affect tumor marker reliability.
    • Hook effects and Tg autoantibody interference pose challenges for specific IMA methods.

    Conclusions:

    • Current serum Tg measurement methods present challenges for reliable DTC monitoring.
    • Standardization and improved assay performance are needed for accurate long-term patient management.
    • Recommendations are provided for manufacturers, laboratories, and clinicians selecting Tg assays.